NBC Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$636K Buy
13,263
+10,511
+382% +$452K 0.04% 453
2026
Q1
$101K Sell
2,752
-83
-3% -$3.93K 0.01% 1091
2025
Q4
$144K Sell
2,835
-395
-12% -$20.2K 0.01% 956
2025
Q3
$179K Sell
3,230
-4,247
-57% -$249K 0.01% 881
2025
Q2
$516K Sell
7,477
-477
-6% -$32.4K 0.04% 479
2025
Q1
$552K Buy
7,954
+7,944
+79,440% +$656K 0.05% 416
2024
Q4
$870 Sell
10
-10,084
-100% -$1.09M 0.08% 268
2024
Q3
$1.2M Sell
10,094
-399
-4% -$53.2K 0.1% 212
2024
Q2
$1.5M Buy
10,493
+2,018
+24% +$267K 0.14% 152
2024
Q1
$1.19M Buy
8,475
+955
+13% +$114K 0.11% 200
2023
Q4
$777K Buy
7,520
+501
+7% +$49.5K 0.08% 271
2023
Q3
$638K Buy
+7,019
New +$618K 0.07% 304

Other funds holding NVO

NBC Securities's NVO Position: Q2 2026 in Review

NBC Securities increased its Novo Nordisk (NVO) stake by 382% in Q2 2026, buying an estimated $452K and bringing the position to 13,263 shares worth $636K. The position accounts for 0.04% of the portfolio, ranked #453.

NBC Securities first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.5M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • NBC Securities held 13,263 shares of Novo Nordisk worth $636K as of Q2 2026.
  • NBC Securities bought 10,511 Novo Nordisk shares in Q2 2026, an estimated $452K.
  • Novo Nordisk made up 0.04% of NBC Securities's portfolio in Q2 2026, its #453 holding.
  • NBC Securities first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Novo Nordisk position peaked at $1.5M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.